|
|
LETTER TO THE EDITOR |
|
Year : 2016 | Volume
: 64
| Issue : 1 | Page : 98 |
|
Vogt-Koyanagi-Harada Syndrome following influenza vaccination
Moosang Kim
Department of Ophthalmology, School of Medicine, Kangwon National University, Chuncheon, Korea
Date of Web Publication | 7-Mar-2016 |
Correspondence Address: Moosang Kim Baengnyeong-ro 156, Chuncheon, Kangwon, Kangwon National University Hospital 200-722 Korea
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/0301-4738.178141
How to cite this article: Kim M. Vogt-Koyanagi-Harada Syndrome following influenza vaccination. Indian J Ophthalmol 2016;64:98 |
Sir,
Uveitis is a rare adverse event of vaccination with a low incidence rate as about 10.5 per 100,000.[1] Vogt-Koyanagi-Harada syndrome More Details is a very rare adverse event of vaccination, and there is only one case report in worldwide.[2] We recently experienced a case of Vogt-Koyanagi-Harada Syndrome following vaccination of influenza, thus herein report the case.
A 52-year-old woman presented to our institution with bilateral red eyes and associated decrease in vision. There was no significant ocular or medical history. However, she had received the influenza vaccination 1 month previously. There was no history of trauma, and the presence of tinnitus was noted on review of the systems. On ocular examination, her best-corrected visual acuities were 20/30 (right) and 20/100 (left). Intraocular pressure was 15 mmHg bilaterally. She never suffered from uveitis previously. The anterior chamber revealed 2+ cells in the both eyes. The fundus appearances demonstrated multifocal serous retinal detachments, which were further confirmed with optical coherence tomography [Figure 1]. Fluorescein angiography showed multiple hyperfluorescent spots [Figure 2]. Laboratory examination showed that both IgM and IgG of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and herpes simplex virus (HSV) were all negative in the serologic evaluation. Systemic steroid therapy was initiated promptly with intravenous methylprednisolone followed by systemic oral corticosteroids (1 mg/kg). Two months after treatment, anterior chamber got clear, and subretinal fluid disappeared. Her visual acuities were 20/20 (right) and 20/25 (left). | Figure 1: Fundus photographs showing bilateral multiple serous retinal detachments (a). Optical coherence tomography demonstrates serous retinal detachment in the both eyes (b)
Click here to view |
| Figure 2: Fluorescein angiography showing multiple hyperfluorescent spots
Click here to view |
This case is unusual in its etiology and presentation, with the development of Vogt-Koyanagi-Harada Syndrome in a woman who had received the influenza vaccination 1 month previously and the presentation of the syndrome with bilateral serous retinal detachments. That the negative finding of IgM and IgG of CMV, EBV, and HSV in the serum of a patient, and the effective use of systemic use of steroid, strongly suggested that the mechanism of uveitis and serous retinal detachments of the patient should be an autoimmune response rather than infectious. We encourage ophthalmologists, rheumatologists, and uveitis specialists to consider influenza vaccine as a cause of Vogt-Koyanagi-Harada Syndrome if the vaccine has been recently administered.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | | |
1. | Klein NP, Ray P, Carpenter D, Hansen J, Lewis E, Fireman B, et al. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine 2010;28:1062-8. |
2. | Gallagher MJ, Yilmaz T, Foster CS. Vogt-Koyanagi-Harada Syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy. Ophthalmic Surg Lasers Imaging 2009;40:345-7. |
[Figure 1], [Figure 2]
This article has been cited by | 1 |
COVID Vaccine-Associated Uveitis |
|
| Zohar Habot-Wilner, Piergiorgio Neri, Annabelle A. Okada, Rupesh Agrawal, Ng Xin Le, Shai Cohen, Naomi Fischer, Fionn Kilmartin, Amy Coman, Dara Kilmartin | | Ocular Immunology and Inflammation. 2023; : 1 | | [Pubmed] | [DOI] | | 2 |
Uveitis including Vogt-Koyanagi-Harada syndrome following inactive covid-19 vaccination: a case series |
|
| Mehrdad Motamed Shariati, Mojtaba Abrishami, Shahin Jahani, Ali Bolouki, Mohamad-Reza Ansari-Astaneh, Seyedeh Maryam Hosseini | | Journal of Ophthalmic Inflammation and Infection. 2023; 13(1) | | [Pubmed] | [DOI] | | 3 |
Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease |
|
| Ke Xu, Bingqian Gao, Jiayi Li, Yixin Xiang, Lin Cao, Mingyi Zhao | | Human Vaccines & Immunotherapeutics. 2023; | | [Pubmed] | [DOI] | | 4 |
Bilateral Relentless Placoid Chorioretinitis Following Pfizer–BioNTech COVID-19 Vaccination: Specific Antigenic Trigger or Nonspecific Immune Activation? |
|
| Deepaysh Dutt Charanjeet Singh Dutt, Jonathan Lam, Josephine Richards | | Ocular Immunology and Inflammation. 2023; : 1 | | [Pubmed] | [DOI] | | 5 |
Ocular manifestations following COVID-19 vaccination |
|
| Padmamalini Mahendradas, Sai Bhakti Mishra, Rohini Sangoram, Sanjay Srinivasan, Ankush Kawali, Aditya Patil, Rohit Shetty | | Journal of Ophthalmic Inflammation and Infection. 2023; 13(1) | | [Pubmed] | [DOI] | | 6 |
Ocular Inflammation Post-Vaccination |
|
| Yaru Zou, Koju Kamoi, Yuan Zong, Jing Zhang, Mingming Yang, Kyoko Ohno-Matsui | | Vaccines. 2023; 11(10): 1626 | | [Pubmed] | [DOI] | | 7 |
Ocular Adverse Events After Influenza Vaccination in Older Adults: Self-Controlled Case Series Using a Large Database in Japan |
|
| Yohei Hashimoto, Masao Iwagami, Hayato Yamana, Sachiko Ono, Yoshinori Takeuchi, Nobuaki Michihata, Kohei Uemura, Makoto Aihara, Hideo Yasunaga | | Ophthalmic Epidemiology. 2023; : 1 | | [Pubmed] | [DOI] | | 8 |
Ocular Adverse Events after Inactivated COVID-19 Vaccination in Xiamen |
|
| Xiuju Chen, Xiaoxin Li, Haibo Li, Minghan Li, Songjian Gong | | Vaccines. 2022; 10(3): 482 | | [Pubmed] | [DOI] | | 9 |
Ocular Inflammatory Reactions following an Inactivated SARS-CoV-2 Vaccine: A Four Case Series |
|
| Junhong Ren, Tingting Zhang, Xiaoyue Li, Guodong Liu | | Ocular Immunology and Inflammation. 2022; : 1 | | [Pubmed] | [DOI] | | 10 |
Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series |
|
| Ling-Uei Wang, Fang-Ting Chen, Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang, Yun-Ju Chen, Yung-Ray Hsu | | Taiwan Journal of Ophthalmology. 2022; 0(0): 0 | | [Pubmed] | [DOI] | | 11 |
Possible Association between Vogt-Koyanagi-Harada Disease and Coronavirus Disease Vaccine: A Report of Four Cases |
|
| Felipe de Queiroz Tavares Ferreira, Daniel Cunha Araújo, Leonardo Mendonça de Albuquerque, Priscila Monaro Bianchini, Erick Carneiro Holanda, Alisson Pugliesi | | Ocular Immunology and Inflammation. 2022; : 1 | | [Pubmed] | [DOI] | | 12 |
Unilateral acute central serous chorioretinopathy with inactivated coronavirus disease 2019 vaccination: A case report and review of literature |
|
| Mojtaba Abrishami, SeyedehMaryam Hosseini, Nasser Shoeibi, HamidReza Heidarzadeh | | Journal of Current Ophthalmology. 2022; 34(3): 373 | | [Pubmed] | [DOI] | | 13 |
Posterior ocular manifestations following BNT162b2 mRNA COVID-19 vaccine: a case series |
|
| Shani Pillar, Tamar Weinberg, Radgonde Amer | | International Ophthalmology. 2022; | | [Pubmed] | [DOI] | | 14 |
Acute-onset Vogt-Koyanagi-Harada-like uveitis following Covid-19 inactivated virus vaccination |
|
| Xiuju Chen, Bin Wang, Xiaoxin Li | | American Journal of Ophthalmology Case Reports. 2022; : 101404 | | [Pubmed] | [DOI] | | 15 |
Vogt-Koyanagi-Harada disease following influenza vaccination |
|
| Fahmeeda Murtaza, Austin Pereira, Mark S. Mandelcorn, Alexander J. Kaplan | | American Journal of Ophthalmology Case Reports. 2022; 26: 101516 | | [Pubmed] | [DOI] | | 16 |
Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination |
|
| Massimo Accorinti, Maria Carmela Saturno, Priscilla Manni | | Ocular Immunology and Inflammation. 2022; : 1 | | [Pubmed] | [DOI] | | 17 |
De Novo Vogt-Koyanagi-Harada Disease following Covid-19 Vaccine: A Case Report and Literature Overview |
|
| Jean-Baptiste Brunet de Courssou, Mylène Tisseyre, Jérôme Hadjadj, Laurent Chouchana, Florent Broca, Benjamin Terrier, Pierre Duraffour, Soledad Henriquez | | Ocular Immunology and Inflammation. 2022; : 1 | | [Pubmed] | [DOI] | | 18 |
Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine |
|
| Janaína Jamile Ferreira Saraceno, Guilherme Macedo Souza, Luciana Peixoto dos Santos Finamor, Heloisa Moraes Nascimento, Rubens Belfort | | International Journal of Retina and Vitreous. 2021; 7(1) | | [Pubmed] | [DOI] | | 19 |
Identification of differently expressed mRNAs by peripheral blood mononuclear cells in Vogt-Koyanagi-Harada disease |
|
| Yujing Li, Guannan Su, Fanfan Huang, Ying Zhu, Xiang Luo, Aize Kijlstra, Peizeng Yang | | Genes & Diseases. 2021; | | [Pubmed] | [DOI] | | 20 |
Pharmacologically induced uveitis |
|
| Maram E.A. Abdalla Elsayed, Igor Kozak | | Survey of Ophthalmology. 2021; 66(5): 781 | | [Pubmed] | [DOI] | | 21 |
Ocular Adverse Events following Yellow Fever Vaccination: A Case Series |
|
| Renato Rodrigues Pereima, Rodolfo Bonatti, Fernanda Crotti, João Marcello Furtado, Marta Heloísa Lopes, Joyce Hisae Yamamoto, André Carvalho Kreuz | | Ocular Immunology and Inflammation. 2021; : 1 | | [Pubmed] | [DOI] | | 22 |
SARS-CoV-2 among the Potential Viral Triggers for Vogt-Konayagi-Harada Disease: First Case Report and Literature Review |
|
| Ana Santamaria, Julian Chang, Christian Savarain | | Ocular Immunology and Inflammation. 2021; : 1 | | [Pubmed] | [DOI] | | 23 |
Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine |
|
| Lin Ru Koong, Wai Kitt Chee, Zhi Hong Toh, Xin Le Ng, Rupesh Agrawal, Su Ling Ho | | Ocular Immunology and Inflammation. 2021; : 1 | | [Pubmed] | [DOI] | | 24 |
Drug-induced uveitis: A review |
|
| Manisha Agarwal, Parthopratim Dutta Majumder, Kalpana Babu, VinayaKumar Konana, Mallika Goyal, Sara Touhami, Dinu Stanescu-Segall, Bahram Bodaghi | | Indian Journal of Ophthalmology. 2020; 68(9): 1799 | | [Pubmed] | [DOI] | |
|
|
|
|